News and Updates

Lilly's retatrutide achieves major success in Phase 3 trials, showing significant weight loss and improved A1C levels via a novel triple-agonist approach.

Ribo’s Phase IIa trial for vortosiran shows positive safety and biomarker results in treating coronary artery disease. Learn about this new approach.

Zydus Lifesciences, in partnership with ICMR, begins Phase III trials for Desidustat to treat Sickle Cell Disease. Learn about this potential new therapy.

Discover how India’s pharmaceutical sector is maintaining steady growth and building global resilience despite evolving US trade and tariff regulations.

AstraZeneca gains EU authorization for a new breast cancer therapy. Learn how this targeted ADC drug is set to transform treatment for HER2-low patients.

Venus Medtech has finished enrolling patients in its PREVAILS trial for the Venus-PowerX TAVR system, a major step toward advancing structural heart care.

The FDA has accepted BridgeBio’s NDA for encaleret, a potential first-in-class treatment for Autosomal Dominant Hypocalcemia Type 1 (ADH1).

LB Pharmaceuticals accelerates the NOVA-2 schizophrenia trial. Discover how this promising drug could redefine treatment standards for psychiatric care.

Discover how a critical two-week observational window in Phase 1 iPSC trials is redefining clinical design and speeding up the path to regulatory approval.

India’s pharma sector hits a two-year growth high as firms prepare for potential U.S. tariff shifts. Read how key manufacturers are navigating global trends.